# The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes

> **NCT03734718** · NA · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 20 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1
- Hypoglycemia

## Interventions

- **DRUG:** GIP

## Key facts

- **NCT ID:** NCT03734718
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2019-12-12
- **Final completion:** 2019-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734718, "The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03734718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*